SkinBioTherapeutics PLC Working Capital to Net Assets Ratio
SkinBioTherapeutics PLC working capital to net assets ratio. SkinBioTherapeutics PLC (SBTX) has a Working Capital to Net Assets ratio of 59.9% as of June 2025. Working capital of GBX5.64 Million (current assets of GBX7.11 Million minus current liabilities of GBX1.47 Million) is measured against net assets of GBX9.42 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. Check SkinBioTherapeutics PLC tangible equity quality to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of SkinBioTherapeutics PLC (2016–2025)
Working capital to net assets ratio of SkinBioTherapeutics PLC from 2016 to 2025. This chart shows how SkinBioTherapeutics PLC's Working Capital to Net Assets ratio has evolved across 10 annual periods from 2016 to 2025. As of June 2025, the ratio stands at 59.9%, reflecting working capital of GBX5.64 Million against net assets of GBX9.42 Million GBX. See SkinBioTherapeutics PLC defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.
SkinBioTherapeutics PLC Working Capital to Net Assets Ratio by Year (2016–2025)
SkinBioTherapeutics PLC working capital to net assets ratio by year from 2016 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for SkinBioTherapeutics PLC from 2016 to 2025, covering 10 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see SkinBioTherapeutics PLC total assets.
| Year | WC/NA Ratio | Working Capital (GBX) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 59.9% | GBX5.64 Million | GBX9.42 Million | GBX7.11 Million | GBX1.47 Million | ▲ +64.4 pp |
| 2024 | -4.5% | GBX-133.29K | GBX2.97 Million | GBX1.67 Million | GBX1.80 Million | ▼ -64.2 pp |
| 2023 | 59.7% | GBX1.19 Million | GBX1.99 Million | GBX1.72 Million | GBX529.74K | ▼ -14.0 pp |
| 2022 | 73.7% | GBX1.82 Million | GBX2.48 Million | GBX2.33 Million | GBX508.96K | ▼ -15.6 pp |
| 2021 | 89.3% | GBX4.66 Million | GBX5.22 Million | GBX5.06 Million | GBX404.89K | ▲ +6.4 pp |
| 2020 | 82.9% | GBX2.04 Million | GBX2.47 Million | GBX2.35 Million | GBX304.83K | ▼ -7.8 pp |
| 2019 | 90.7% | GBX3.46 Million | GBX3.81 Million | GBX3.58 Million | GBX121.33K | ▼ -0.9 pp |
| 2018 | 91.6% | GBX3.15 Million | GBX3.44 Million | GBX3.36 Million | GBX209.29K | ▼ -3.2 pp |
| 2017 | 94.9% | GBX4.00 Million | GBX4.21 Million | GBX4.12 Million | GBX118.66K | ▲ +29.8 pp |
| 2016 | 65.1% | GBX253.63K | GBX389.85K | GBX287.27K | GBX33.64K | — |